Net Cash Provided by (Used in) Financing Activities in USD of RESMED INC from 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Resmed Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2010 to Q3 2025.
  • Resmed Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending 30 Sep 2025 was -$230M, a 52.7% decline year-over-year.
  • Resmed Inc annual Net Cash Provided by (Used in) Financing Activities for 2025 was -$606M, a 45.8% increase from 2024.
  • Resmed Inc annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$1.12B, a 365% decline from 2023.
  • Resmed Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $423M.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

RESMED INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$230M -$79.5M -52.7% 01 Jul 2025 30 Sep 2025 10-Q 31 Oct 2025
Q3 2024 -$151M +$375K +0.25% 01 Jul 2024 30 Sep 2024 10-Q 31 Oct 2025
Q3 2023 -$151M -$109M -261% 01 Jul 2023 30 Sep 2023 10-Q 25 Oct 2024
Q3 2022 -$41.9M -$135M -145% 01 Jul 2022 30 Sep 2022 10-Q 27 Oct 2023
Q3 2021 $93M +$268M 01 Jul 2021 30 Sep 2021 10-Q 28 Oct 2022
Q3 2020 -$175M -$75.2M -75.1% 01 Jul 2020 30 Sep 2020 10-Q 29 Oct 2021
Q3 2019 -$100M -$245M -169% 01 Jul 2019 30 Sep 2019 10-Q 30 Oct 2020
Q3 2018 $145M +$251M 01 Jul 2018 30 Sep 2018 10-Q 25 Oct 2019
Q3 2017 -$106M 01 Jul 2017 30 Sep 2017 10-Q 26 Oct 2018
Q3 2012 $7.69M +$91.6M 01 Jul 2012 30 Sep 2012 10-Q 31 Oct 2012
Q3 2011 -$83.9M -$47.5M -130% 01 Jul 2011 30 Sep 2011 10-Q 31 Oct 2012
Q3 2010 -$36.5M 01 Jul 2010 30 Sep 2010 10-Q 03 Nov 2011

RESMED INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 -$606M +$513M +45.8% 01 Jul 2024 30 Jun 2025 10-K 08 Aug 2025
2024 -$1.12B -$1.54B -365% 01 Jul 2023 30 Jun 2024 10-K 08 Aug 2025
2023 $423M +$551M 01 Jul 2022 30 Jun 2023 10-K 08 Aug 2025
2022 -$128M +$636M +83.2% 01 Jul 2021 30 Jun 2022 10-K 09 Aug 2024
2021 -$765M -$447M -141% 01 Jul 2020 30 Jun 2021 10-K 11 Aug 2023
2020 -$317M -$898M -155% 01 Jul 2019 30 Jun 2020 10-K 12 Aug 2022
2019 $581M +$1.61B 01 Jul 2018 30 Jun 2019 10-K 17 Aug 2021
2018 -$1.03B -$764M -291% 01 Jul 2017 30 Jun 2018 10-K 13 Aug 2020
2017 -$263M -$875M -143% 01 Jul 2016 30 Jun 2017 10-K 08 Aug 2019
2016 $613M 01 Jul 2015 30 Jun 2016 10-K 17 Aug 2018
2013 -$154M +$23.2M +13.1% 01 Jul 2012 30 Jun 2013 10-K 13 Aug 2013
2012 -$177M -$97.8M -123% 01 Jul 2011 30 Jun 2012 10-K 13 Aug 2013
2011 -$79.3M -$18.2M -29.8% 01 Jul 2010 30 Jun 2011 10-K 13 Aug 2013
2010 -$61.1M 01 Jul 2009 30 Jun 2010 10-K 14 Aug 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.